{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:39:35Z","timestamp":1792823975165,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004610","name":"Science and Technology Support Program of Jiangsu Province","doi-asserted-by":"publisher","award":["ZDXK202234"],"award-info":[{"award-number":["ZDXK202234"]}],"id":[{"id":"10.13039\/501100004610","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012154","name":"Graduate Research and Innovation Projects of Jiangsu Province","doi-asserted-by":"publisher","award":["KYCX25 3790"],"award-info":[{"award-number":["KYCX25 3790"]}],"id":[{"id":"10.13039\/501100012154","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.canlet.2026.218867","type":"journal-article","created":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:23:00Z","timestamp":1791008580000},"page":"218867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Targeting the metabolic-immune regulator SLC35F6 enhances temozolomide and anti-PD-L1 therapy in glioma"],"prefix":"10.1016","volume":"661","author":[{"given":"Pengpeng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1276-5962","authenticated-orcid":false,"given":"Jianfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.canlet.2026.218867_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202503866","article-title":"Prickle4 drives microenvironmental remodeling and resistance to parp inhibition in IDH-mutant glioma","volume":"13","author":"Yang","year":"2026","journal-title":"Adv. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2174\/0115748928280901231206102637","article-title":"TENT5A increases glioma malignancy and promotes its progression","volume":"20","author":"Hu","year":"2025","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.canlet.2026.218867_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217805","article-title":"Aberrant PLAC8 expression characterizes glioblastoma with temozolomide resistance and an immunosuppressive microenvironment","volume":"625","author":"She","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218867_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101122","article-title":"Framework nucleic acid-based nanoparticles enhance temozolomide sensitivity in glioblastoma","volume":"76","author":"Lan","year":"2024","journal-title":"Drug Resist. Updates"},{"issue":"10412","key":"10.1016\/j.canlet.2026.218867_bib5","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1016\/S0140-6736(23)01054-1","article-title":"Primary brain tumours in adults","volume":"402","author":"van den Bent","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.canlet.2026.218867_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2025.115702","article-title":"In vitro models of the interplay between glioblastoma and blood-brain barrier for stratifying drug efficacy","volume":"227","author":"Ferreira","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13046-024-03175-9","article-title":"The dual role of POSTN in maintaining glioblastoma stem cells and the immunosuppressive phenotype of microglia in glioblastoma","volume":"43","author":"Wang","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib9","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/s41419-025-07569-1","article-title":"Generation and validation of a novel multitarget small molecule in glioblastoma","volume":"16","author":"Artetxe-Zurutuza","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218867_bib10","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jconrel.2022.03.019","article-title":"Enhanced BBB and BBTB penetration and improved anti-glioma behavior of Bortezomib through dual-targeting nanostructured lipid carriers","volume":"345","author":"Farshbaf","year":"2022","journal-title":"J. Contr. Release"},{"issue":"2","key":"10.1016\/j.canlet.2026.218867_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.2174\/1574892816666210729125802","article-title":"Circular RNA NF1-419 inhibits proliferation and induces apoptosis by regulating lipid metabolism in astroglioma cells","volume":"17","author":"Li","year":"2022","journal-title":"Recent Pat. Anticancer Drug Discov."},{"issue":"2","key":"10.1016\/j.canlet.2026.218867_bib12","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163450","article-title":"Impact of epigenetic reprogramming on antitumor immune responses in glioma","volume":"133","author":"McClellan","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"9","key":"10.1016\/j.canlet.2026.218867_bib13","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.ccell.2022.07.011","article-title":"De novo pyrimidine synthesis is a targetable vulnerability in IDH mutant glioma","volume":"40","author":"Shi","year":"2022","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218867_bib14","article-title":"Metal-based nanomaterials achieve tumor treatment strategies by overcoming the blood-brain barrier of glioma and responding to the tumor microenvironment","volume":"36","author":"Wang","year":"2026","journal-title":"Mater. Today Bio"},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13046-021-02078-3","article-title":"Cyclin G2 reverses immunosuppressive tumor microenvironment and potentiates PD-1 blockade in glioma","volume":"40","author":"Li","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218867_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neuroscience.2025.12.046","article-title":"Predictive and prognostic value of a glucose metabolism disorder and immune-related gene signature in glioma","volume":"602","author":"Lin","year":"2026","journal-title":"Neuroscience"},{"issue":"19","key":"10.1016\/j.canlet.2026.218867_bib17","doi-asserted-by":"crossref","first-page":"4896","DOI":"10.1158\/0008-5472.CAN-21-2647","article-title":"Cancer signaling drives cancer metabolism: AKT and the warburg effect","volume":"81","author":"Hosios","year":"2021","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.canlet.2026.218867_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41419-020-2520-2","article-title":"NF-kappa B interacting long noncoding RNA enhances the Warburg effect and angiogenesis and is associated with decreased survival of patients with gliomas","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218867_bib19","article-title":"Glucose oxidase-powered nanocatalytic medicine: rewiring tumor metabolism for multimodal cancer therapy","volume":"36","author":"Wang","year":"2026","journal-title":"Mater. Today Bio"},{"issue":"4","key":"10.1016\/j.canlet.2026.218867_bib20","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/neuonc\/noac231","article-title":"Homeobox A3 and KDM6A cooperate in transcriptional control of aerobic glycolysis and glioblastoma progression","volume":"25","author":"Yang","year":"2023","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218867_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101329","article-title":"Endothelial cells sense temozolomide resistance to facilitate monocyte-derived macrophage infiltration in glioblastoma","volume":"84","author":"Gao","year":"2026","journal-title":"Drug Resist. Updates"},{"issue":"36","key":"10.1016\/j.canlet.2026.218867_bib22","doi-asserted-by":"crossref","first-page":"3364","DOI":"10.1038\/s41388-025-03497-8","article-title":"Unveiling the role of TAM-derived extracellular vesicles in glioma progression through Treg polarization and immune suppression","volume":"44","author":"Zhang","year":"2025","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41419-026-08701-5","article-title":"Targeting the tumor microenvironment: reprogramming macrophages as a novel therapeutic strategy in FUOM-deficient glioblastoma","volume":"17","author":"Lu","year":"2026","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib25","doi-asserted-by":"crossref","DOI":"10.1172\/JCI163446","article-title":"Macrophages and microglia in glioblastoma: heterogeneity, plasticity, and therapy","volume":"133","author":"Khan","year":"2023","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib26","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41698-025-01198-9","article-title":"The regulatory roles and therapeutic strategies of the solute carrier transporters in cancer metabolism","volume":"10","author":"Zhang","year":"2026","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218867_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218222","article-title":"Roles and therapeutic targeting of SLC transporters in gastrointestinal malignancies","volume":"639","author":"Wang","year":"2026","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s13000-024-01582-2","article-title":"Clinical significance and expression of SLC35F6 in bladder urothelial carcinoma","volume":"19","author":"Zhang","year":"2024","journal-title":"Diagn. Pathol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218867_bib29","doi-asserted-by":"crossref","first-page":"6718","DOI":"10.3390\/ijms25126718","article-title":"Residence of the nucleotide sugar transporter family members SLC35F1 and SLC35F6 in the endosomal\/lysosomal pathway","volume":"25","author":"Van den Bossche","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.canlet.2026.218867_bib30","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1093\/neuonc\/noad100","article-title":"Molecular diagnostic tools for the World Health Organization (WHO) 2021 classification of gliomas, glioneuronal and neuronal tumors; an EANO guideline","volume":"25","author":"Sahm","year":"2023","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218867_bib31","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ajpath.2024.01.011","article-title":"Basic transcription factor 3 like 4 enhances malignant phenotypes through modulating tumor cell function and immune microenvironment in Glioma","volume":"194","author":"Lu","year":"2024","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2026.218867_bib32","article-title":"KRTCAP2 accelerates malignant progression through modulating tumor cell function and M2 macrophage infiltration in glioma","volume":"17","author":"Zhao","year":"2026","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/s12934-023-02090-6","article-title":"Advances in the optimization of central carbon metabolism in metabolic engineering","volume":"22","author":"Wu","year":"2023","journal-title":"Microb. Cell Fact."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib34","article-title":"Single-cell RNA sequencing analysis revealed the immunosuppressive remodeling of tumor-associated macrophages mediated by the MIF-CD74 axis in gastric cancer","volume":"15","author":"Liu","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib35","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13045-023-01478-6","article-title":"Metabolism, metabolites, and macrophages in cancer","volume":"16","author":"Li","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.canlet.2026.218867_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2025.123625","article-title":"Multifunctional copper-light synergistic prodrug nanosystems for specific reprogramming of tumour immunogenic endoplasmic reticulum stress","volume":"325","author":"Lu","year":"2026","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib37","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41467-024-44963-3","article-title":"Redox-responsive polymer micelles co-encapsulating immune checkpoint inhibitors and chemotherapeutic agents for glioblastoma therapy","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.canlet.2026.218867_bib38","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1200\/JCO.18.01207","article-title":"Buparlisib in patients with recurrent glioblastoma harboring phosphatidylinositol 3-Kinase pathway activation: an open-label, multicenter, multi-arm, phase II trial","volume":"37","author":"Wen","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.canlet.2026.218867_bib39","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/neuonc\/nox044","article-title":"Combination therapy with potent PI3K and MAPK inhibitors overcomes adaptive kinome resistance to single agents in preclinical models of glioblastoma","volume":"19","author":"McNeill","year":"2017","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218867_bib57","article-title":"Reversing Temozolomide Resistance in Glioblastoma Based on Cuproptosis\u2010Mediated Positive Feedback Loop","author":"Feng","year":"2026","journal-title":"Adv. Sci."},{"issue":"29","key":"10.1016\/j.canlet.2026.218867_bib58","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202400502","article-title":"Dual\u2010Targeted Novel Temozolomide Nanocapsules Encapsulating siPKM2 Inhibit Aerobic Glycolysis to Sensitize Glioblastoma to Chemotherapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"issue":"2","key":"10.1016\/j.canlet.2026.218867_bib43","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1038\/s41568-019-0216-7","article-title":"The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism","volume":"20","author":"Hoxhaj","year":"2020","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.canlet.2026.218867_bib44","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/neuonc\/noae222","article-title":"Glutamate dehydrogenase 1-catalytic glutaminolysis feedback activates EGFR\/PI3K\/AKT pathway and reprograms glioblastoma metabolism","volume":"27","author":"Yang","year":"2025","journal-title":"Neuro Oncol."},{"issue":"5","key":"10.1016\/j.canlet.2026.218867_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114119","article-title":"A p85 isoform switch enhances PI3K activation on endosomes by a MAP4- and PI3P-dependent mechanism","volume":"43","author":"Thapa","year":"2024","journal-title":"Cell Rep."},{"issue":"5","key":"10.1016\/j.canlet.2026.218867_bib46","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1158\/0008-5472.CAN-22-1570","article-title":"Phagocytosis of glioma cells enhances the immunosuppressive phenotype of bone marrow-derived macrophages","volume":"83","author":"Wu","year":"2023","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.canlet.2026.218867_bib47","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1093\/neuonc\/noaf157","article-title":"CAF-derived LRRC15 orchestrates macrophage polarization and limits PD-1 immunotherapy efficacy in glioblastoma","volume":"27","author":"Luo","year":"2025","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.canlet.2026.218867_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.218126","article-title":"Single-cell deconstruction of medulloblastoma microenvironment elucidates subtype-specific immune architectures and prognostic molecular signatures","volume":"636","author":"Zhou","year":"2026","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.canlet.2026.218867_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.112197","article-title":"Single-cell RNA sequencing reveals immunosuppressive myeloid cell diversity during malignant progression in a murine model of glioma","volume":"42","author":"Rajendran","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218867_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112187","article-title":"Silencing BMAL1 promotes M1\/M2 polarization through the LDHA\/lactate axis to promote GBM sensitivity to bevacizumab","volume":"134","author":"Wang","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib60","article-title":"Exploring tumor-associated macrophages in glioblastoma: from diversity to therapy","volume":"9","author":"Zhao","year":"2025","journal-title":"NPJ Precis. Oncol."},{"issue":"19","key":"10.1016\/j.canlet.2026.218867_bib50","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.3390\/cancers16193300","article-title":"Blood-brain barrier conquest in glioblastoma nanomedicine: strategies, clinical advances, and emerging challenges","volume":"16","author":"Duan","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218867_bib51","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jconrel.2024.07.014","article-title":"Brain-targeted drug delivery by in vivo functionalized liposome with stable D-peptide ligand","volume":"373","author":"Yang","year":"2024","journal-title":"J. Contr. Release"},{"issue":"19","key":"10.1016\/j.canlet.2026.218867_bib52","doi-asserted-by":"crossref","first-page":"12187","DOI":"10.1039\/D5NR00984G","article-title":"Tuning lipid nanocarrier mechanical properties to improve glioblastoma targeting and blood brain barrier penetration","volume":"17","author":"Robles-Fern\u00e1ndez","year":"2025","journal-title":"Nanoscale"},{"key":"10.1016\/j.canlet.2026.218867_bib53","first-page":"126","article-title":"Extracellular vesicles in nanomedicine and regenerative medicine: a review over the last decade","volume":"36","author":"Moghassemi","year":"2024","journal-title":"Bioact. Mater."},{"issue":"1","key":"10.1016\/j.canlet.2026.218867_bib54","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s40035-024-00453-6","article-title":"Extracellular vesicles: biological mechanisms and emerging therapeutic opportunities in neurodegenerative diseases","volume":"13","author":"Wang","year":"2024","journal-title":"Transl. Neurodegener."},{"issue":"15","key":"10.1016\/j.canlet.2026.218867_bib55","doi-asserted-by":"crossref","first-page":"14191","DOI":"10.1021\/acsanm.3c02122","article-title":"Transferrin-conjugated PLGA nanoparticles for Co-Delivery of temozolomide and bortezomib to glioblastoma cells","volume":"6","author":"Ramalho","year":"2023","journal-title":"ACS Appl. Nano Mater."},{"issue":"8","key":"10.1016\/j.canlet.2026.218867_bib56","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12255","article-title":"Specific anti-glioma targeted-delivery strategy of engineered small extracellular vesicles dual-functionalised by Angiopep-2 and TAT peptides","volume":"11","author":"Zhu","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"23","key":"10.1016\/j.canlet.2026.218867_bib61","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1038\/s41388-025-03454-5","article-title":"Post-translational modifications in DNA damage repair: mechanisms underlying temozolomide resistance in glioblastoma","volume":"44","author":"Chen","year":"2025","journal-title":"Oncogene"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526006312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T06:21:27Z","timestamp":1792822887000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526006312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":57,"alternative-id":["S0304383526006312"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218867","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting the metabolic-immune regulator SLC35F6 enhances temozolomide and anti-PD-L1 therapy in glioma","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"218867"}}